Leavitt Partners, an HMA Company, is pleased to announce that Julie Tierney has joined the company’s team of health policy experts as a principal, located in Washington, D.C. Tierney is a proven executive with more than 20 years of FDA legal, policy, and operational experience. She held a number of senior roles at FDA, including … Continue reading
A recent survey conducted by WEDI, a national association for health IT guidance and collaboration, underscores significant delays among both providers and health plans in preparing for The Centers for Medicare & Medicaid Services (CMS)’s Interoperability and Prior Authorization Final Rule (CMS-0057-F). The rule introduces new requirements-including Fast Healthcare Interoperability Resources (FHIR) implementation and prior authorization … Continue reading
Leavitt Partners, an HMA Company, is pleased to announce that Conor Sheehey has joined the company’s team of health policy experts as a director, located in Washington, D.C. Sheehey most recently served as senior health policy advisor to U.S. Senate Finance Committee Chair Mike Crapo (R-ID). In this role, he advised the Committee on a … Continue reading
We are pleased to announce that Josh Trent has been named chief executive officer (CEO) of Leavitt Partners, an HMA Company. He succeeds Vince Ventimiglia who founded and successfully led Leavitt Partner’s Washington, D.C., office for more than a decade. Vince continues his service at Leavitt Partners in the role of senior advisor where he … Continue reading
Leavitt Partners, an HMA Company, is pleased to welcome Kim Boyd to the company’s team of digital health experts. She will serve as a principal with the Washington, DC office, and as a resident of Nashville, Tennessee will have close ties with HMA’s Nashville office. Kim has extensive experience in health IT, having served as … Continue reading
Background and Problem Statement As a consequence of recent progress in interoperability and healthcare data exchange, the data quality problem is no longer isolated to local organizations and businesses; it is systemic and more evident than ever. It negatively affects patient care, patient safety, public health, clinical research, insurance claims processing, and the administrative cost … Continue reading
25 Tribal Organizations, Medical Schools and Others to Advocate for Policies that Empower New Physicians to Practice in Tribal Communities. Today, 25 urban and rural Tribal organizations, medical schools, health plans, teaching hospitals, medical residencies, and physician advocates launched the American Indian Medical Education Strategies (AIMES) Alliance. The AIMES Alliance, whose mission is to address … Continue reading
Leavitt Partners, an HMA Company, is pleased to announce that Mark Marciante has joined the company’s digital health team of experts. He will be a director located in the company’s Washington, D.C., office. Marciante has extensive experience in digital health, successfully driving transformative initiatives for healthcare payers over the past decade. As director of engineering … Continue reading
The 2024 election cycle will dominate the headlines, but there will be meaningful health policy both in Congress and in the Biden Administration. This year the Leavitt Partners Political Checkpoint is a video featuring Governor Michael Leavitt and members of our D.C. team talking about short term and longer term outlook on major issues and the … Continue reading
The Save Rare Treatments Task Force, a new multi-sector public policy and advocacy collaboration convened by Leavitt Partners, an HMA Company, publicly launched this week and today released a letter of support for recently introduced, bipartisan, bicameral legislation. The Task Force is comprised of organizations representing persons living with rare diseases, biopharmaceutical innovators, and other … Continue reading
